SynthesisAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2024

Safety and Efficacy of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors After Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials.

Ahmed Atia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.